According to Santhera Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -A$84.81 M. In 2023 the company made an earning of A$0.13 B an increase over its 2022 earnings that were of -A$81.88 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.